Complementary mass spectrometry based detection of gangliosides and other lipids in the brain

基本原理：神经节苷脂是中枢神经系统（CNS）内富集的主要类别的鞘糖脂，并且与脑中的其他脂质一样，在包括膜功能、轴突稳定性和再生、分化和神经变性的广泛活动中发挥主要作用。 利用NSERC的资金，我们的实验室开发并使用了包括成像质谱（IMS）在内的互补质谱（MS）方法，以表明神经元对脂质微环境内的变化高度敏感。 具体来说，我们已经发表了有害的神经节苷脂GM2和GM3在小鼠和大鼠以及大脑中的神经元受到应激刺激后短暂增加，并且增强神经保护性神经节苷脂GM1在体外和体内保护神经元免于细胞死亡。基于这些已发表的和初步的研究，我们假设神经节苷脂GM2和GM3在神经元应激后短暂增加。 我们进一步预测，阻止GM1分解为GM2和GM3可以防止神经退行性变。** 目标：该提案建立在我们目前的NSERC资金基础上，具有以下目标：*1）在体外和体内使用siRNA方法靶向神经节苷脂降解途径中的酶，以瞬时增加神经元内的GM 1。 这将使我们能够测试这样一个假设，即内在地和短暂地增加GM1可以保护神经元免受细胞死亡。2)建立和扩大我们目前的lipidomic程序通过扩展成像质谱的能力，以检测和成像其他类别的脂质，如甘油磷脂和鞘脂在啮齿动物模型的老化和神经变性 ** 方法：神经节苷脂，像其他脂质，包含在不同的细胞隔室的大脑，并有能力改变其结构，以满足其外部和内部的环境需求。 这种改变结构的能力使得脂质既迷人又具有技术挑战性，难以识别和理解。 为了应对这一挑战，我们采用互补质谱（MS）技术，包括成像质谱（IMS），直接在脑组织内检测和成像神经节苷脂。 我们将使用药理学和siRNA介导的干预来防止GM1分解为GM2和GM3，以进一步验证GM2和GM3是神经退行性变的基本介质。最后，我们将扩大IMS的能力，对大脑中的其他脂质进行成像，以更好地了解脂质在介导神经变性脆弱性中的作用。意义：该提议将增加关于神经节苷脂和其他脂质在介导神经元脆弱性和神经变性中的作用的知识。该提案还将推动基于IMS的完整组织样本内脂质检测的界限。 *****

Rationale: Gangliosides are a major class of glycosphingolipids enriched within the central nervous system (CNS), and like other lipids in the brain play a major role in a wide range of activities including membrane function, axon stability and regeneration, differentiation and neurodegeneration. Using NSERC funding, our lab has developed and used complementary mass spectrometry (MS) approaches including imaging mass spectrometry (IMS) to show that neurons are highly sensitive to changes within the lipid microenvironment. Specifically, we've published that harmful gangliosides GM2 and GM3 are transiently increased following stressful stimuli to neurons in the mouse and rat and brain and that enhancing neuroprotective ganglioside GM1 protects neurons from cell death in vitro and in vivo. Based on these published and preliminary studies we hypothesize that gangliosides GM2 and GM3 are transiently increased following neuronal stress. We further predict that preventing the breakdown of GM1 into GM2 and GM3 can prevent neurodegeneration. ******Objectives: This proposal builds upon our current NSERC funding with the following objectives:***1) Use siRNA approaches both in vitro and in vivo to target enzymes within the ganglioside degradation pathway to transiently increase GM1 within neurons. This will allow us to test the hypothesis that intrinsically and transiently increasing GM1 can protect neurons against cell death.******2) Build and expand our current lipidomic program by extending imaging mass spectrometry capabilities to detect and image other classes of lipids such as glycerophospholipids and sphingolipids in rodent models of aging and neurodegeneration******Approach: Gangliosides, like other lipids, are contained within different cellular compartments of the brain and have the ability to change their structure to meet their external and internal environmental demands. This ability to change structure makes lipids both fascinating and technologically challenging targets to identify and understand. To meet this challenge, we employ complementary mass spectrometry (MS) techniques, including imaging mass spectrometry (IMS) to detect and image gangliosides directly within brain tissue. We will use pharmacological and siRNA mediated intervention to prevent the breakdown of GM1 into GM2 and GM3 to further validate that GM2 and GM3 are fundamental mediators of neurodegeneration. Finally, we will expand our IMS capabilities to image additional lipids within the brain to gain a better understanding on the role for lipids in mediating vulnerability to neurodegeneration.******Significance: This proposal will add knowledge on the role of gangliosides and other lipids in mediating neuronal vulnerability and neurodegeneration. This proposal will also push the boundaries of IMS based detection of lipids within intact tissue samples. *****